Pharma Can Be Liable For Design Negligence: Pa. High Court
Law360, Philadelphia (January 22, 2014, 1:35 PM EST) -- The Pennsylvania Supreme Court ruled Tuesday that pharmaceutical companies can be held liable for negligence in the design and marketing of drugs, upholding a ruling against a Pfizer Inc. subsidiary in a case over a death that allegedly stemmed from its diet drug Redux.
In a 4-2 ruling, the justices rejected drugmaker Wyeth Ltd.'s arguments that pharmaceutical companies can only be held liable in Pennsylvania for manufacturing defects and inadequate warnings, and they declined to impose a bright-line rule barring all claims over the design of drugs.
"Under Pennsylvania law, pharmaceutical companies violate their duty of care if they introduce a...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!